Alcohol Use Disorder: Clinical Trials

10 trials for Alcohol Use Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 10

Follow Alcohol Use Disorder: new trials by email Literature Review of Alcohol Use Disorder trials Research Report on Alcohol Use Disorder

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cytisine for Smoking Cessation
Cytisine, Placebo - Tobacco Use Disorder, Alcohol Use Disorder
Phase 4CompletedCentre for Addiction and Mental Health202023-02-082026-02-27
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome
Acamprosate, Placebo - Alcohol Use Disorder
Phase 4CompletedMayo Clinic2882019-07-152024-12-17
Alcohol Disorder hOsPital Treatment Trial
Oral naltrexone (PO-NTX), Extended-release injectable naltrexone (XR-NTX) - Heavy Drinking, Alcohol Dependence
Phase 4CompletedBoston University2482016-06-012021-06-29
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
Placebo, Citicoline, Pregnenolone - Alcohol Use Disorder, Bipolar Disorder
Phase 4CompletedSherwood Brown, MD, PhD962016-05-012024-10-09
Neural Mechanisms of Disulfiram Effects
Disulfiram - Alcohol Use Disorder
Phase 4CompletedNew York State Psychiatric Institute72016-03-012020-11-23
Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users
XR-NTX+CM (Extended-Release Naltrexone plus Care Management) - Alcohol Dependence, Alcohol Use Disorder
Phase 4CompletedNYU Langone Health502015-07-012022-05-11
Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
oral naltrexone, Placebo pill - HIV, Alcohol Use Disorder
Phase 4CompletedFred Hutchinson Cancer Center1592014-05-012017-06-16
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
Ondansetron, Placebo - Bipolar Disorder, Alcohol Use Disorder
Phase 4CompletedUniversity of Texas Southwestern Medical Center702014-02-012021-08-24
Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems
Sertraline, Placebo - PTSD, Alcohol Use Disorder
Phase 4CompletedThe University of Texas Health Science Center at San Antonio492011-04-012018-04-10
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Paroxetine, Placebo - Social Anxiety Disorder, Social Phobia
Phase 4CompletedMedical University of South Carolina422002-03-012018-09-27

Narrower conditions

Alcoholism (10)  ·  Bipolar Disorder (2)  ·  Alcohol-Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Emergencies (1)  ·  Mental Disorders (1)  ·  Patient Acceptance of Health Care (1)  ·  Phobia, Social (1)  ·  Smoking Cessation (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Alcohol-Related Disorders (9)  ·  Chemically-Induced Disorders (9)  ·  Mental Disorders (9)  ·  Substance-Related Disorders (9)  ·  Behavior (2)  ·  Bipolar and Related Disorders (2)  ·  Health Behavior (2)  ·  Mood Disorders (2)  ·  Anxiety Disorders (1)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Phobic Disorders (1)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Naltrexone (2)  ·  Sugars (2)  ·  vivitrol (2)  ·  Acamprosate (1)  ·  Cytidine Diphosphate Choline (1)  ·  Disulfiram (1)  ·  Ondansetron (1)  ·  Paroxetine (1)  ·  Pregnenolone (1)  ·  Sertraline (1)  ·  cytisine (1)

Sponsors

Boston University (1)  ·  Centre for Addiction and Mental Health (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Medical University of South Carolina (1)  ·  NYU Langone Health (1)  ·  New York State Psychiatric Institute (1)  ·  Sherwood Brown, MD, PhD (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (8)  ·  Canada (1)  ·  Peru (1)

Top investigators

Ann Duerr, MD, PhD, MPH (1)  ·  Bernard Le Foll (1)  ·  Carrie L Randall, PhD (1)  ·  E. Sherwood Brown, MD, PhD (1)  ·  Frederick Altice, MD (1)  ·  John D Roache, PhD (1)  ·  Nasir H. Naqvi, MD, PhD (1)  ·  Richard Saitz, MD, MPH (1)  ·  Ryan P McCormack, MD (1)  ·  Victor M Karpyak, MD, Ph.D. (1)

Results publications

PMID 35285015, PMID 40257810

NIH funding

K23AA022989 (1), R01AA013379 (1), R01AA021335 (1), R01AA027486 (1), U01AA027487 (1)